KT

Kelsey Tsai

Vice President, Sandbox Healthcare at Sandbox Industries

Greater Chicago Area

Overview 

Kelsey Tsai is a Healthcare VC at Sandbox Healthcare & The Blue Venture Fund in the Greater Chicago Area, with a strong background in healthcare investment and a Master of Business Administration from The University of Chicago Booth School of Business. Notable career highlights include serving as Vice President at Sandbox Industries and The Blue Venture Fund, showcasing expertise in digital health, health IT, and Midwest healthcare sectors.

Work Experience 

  • Advisor

    2024 - Current

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

Raised $33,000,000.00 from National Cancer Institute.

  • Founder & Consultant

    2024

    Life science and healthcare consulting, advising entrepreneurs and startups on strategy, commercialization, fundraising, and business development.

  • Vice President, Sandbox Healthcare

    2021 - 2024

    Sandbox invests in technologies that drive lasting change in human livelihood and transform healthcare, sustainability and insurance & financial services. It is the exclusive investment management services provider of The Blue Venture Fund, which manages >$1B across five funds with 35 Blue Cross Blue Shield plans, and Sandbox Clinical Ventures, which focuses on accelerating clinical innovation by investing in companies with transformative diagnostic, device and lab technologies.

  • Associate, Sandbox Healthcare

    2020 - 2021

Sandbox bridges the gap between startups and corporations in three ways: strategic venture funds, accelerators, and consulting services.

  • Investment Banking Summer Associate

    2019 - 2019

J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .

  • MBA Associate

    2018 - 2019

    ARCH Venture Partners is a venture capital firm that creates and invests in ground-breaking life science and technology companies.

ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.

  • Equity Analyst, Biotechnology

    2016 - 2018

    Morningstar is a leading financial services firm providing investment research, data, and tools for investors, offering insights on mutual funds, ETFs, stocks, and portfolio management. Lead coverage of mid- and large-cap biotech (ALNY, ALXN, EXEL, GMAB, ICPT, INCY, IONS, JAZZ, KITE, LUN, SGEN, UCB, UTHR, VRTX) and CRO/CDMOs (CRL, ICON, IQV, LONN, PRXL)

  • Associate Equity Analyst, Healthcare

    2015 - 2016

  • Data Analyst, Managed Investments

    2013 - 2015

Morningstar provides independent investment research to investors worldwide.

Raised $91,000,000.00 from SoftBank Capital.

Articles About Kelsey

Relevant Websites